Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2007-6-27
pubmed:abstractText
Dehydroepiandrosterone (DHEA) is an endogenous steroid that is metabolized to androgens and/or estrogens in the human prostate. DHEA levels decline with age, and use of DHEA supplements to retard the aging process is of unproved effectiveness and safety. LNCaP and LAPC-4 prostate cancer cells were used to determine whether DHEA-modulated proliferation and prostate specific antigen (PSA) production were mediated via the androgen receptor (AR) and/or ERbeta.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Androgen Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Anilides, http://linkedlifedata.com/resource/pubmed/chemical/Dehydroepiandrosterone, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor beta, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Androgen, http://linkedlifedata.com/resource/pubmed/chemical/Testosterone, http://linkedlifedata.com/resource/pubmed/chemical/Tosyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/bicalutamide, http://linkedlifedata.com/resource/pubmed/chemical/dehydrotestosterone, http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0270-4137
pubmed:author
pubmed:copyrightInfo
(c) 2007 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1152-62
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17503469-Androgen Antagonists, pubmed-meshheading:17503469-Androgen Receptor Antagonists, pubmed-meshheading:17503469-Anilides, pubmed-meshheading:17503469-Cell Division, pubmed-meshheading:17503469-Cell Line, Tumor, pubmed-meshheading:17503469-Dehydroepiandrosterone, pubmed-meshheading:17503469-Estradiol, pubmed-meshheading:17503469-Estrogen Antagonists, pubmed-meshheading:17503469-Estrogen Receptor beta, pubmed-meshheading:17503469-Gene Expression, pubmed-meshheading:17503469-Humans, pubmed-meshheading:17503469-Male, pubmed-meshheading:17503469-Nitriles, pubmed-meshheading:17503469-Prostate-Specific Antigen, pubmed-meshheading:17503469-Prostatic Neoplasms, pubmed-meshheading:17503469-RNA, Messenger, pubmed-meshheading:17503469-RNA, Small Interfering, pubmed-meshheading:17503469-Receptors, Androgen, pubmed-meshheading:17503469-Testosterone, pubmed-meshheading:17503469-Tosyl Compounds
pubmed:year
2007
pubmed:articleTitle
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
pubmed:affiliation
Endocrine Section, Laboratory of Clinical Investigation, Division of Intramural Research, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, Maryland 20892-0933, USA. jarnold@mail.nih.gov
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural